((1R,2R)-2-(((tert-butyldiphenylsilyl)oxy)methyl)cyclopropyl)methanol | 154001-59-9

• 分子结构分类: 有机化合物 - 有机金属化合物 - 有机类金属化合物
• 英文名称: ((1R,2R)-2-(((tert-butyldiphenylsilyl)oxy)methyl)cyclopropyl)methanol
• 英文别名: [(1R,2R)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]cyclopropyl]methanol
• CAS: 154001-59-9
• 化学式: C₂₁H₂₈O₂Si
• 分子量: 340.538
• InChiKey: UDQZGHRUSQGZFC-ROUUACIJSA-N

物化性质

• 沸点：
  409.7±27.0 °C(Predicted)
• 密度：
  1.06±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.19
• 重原子数：
  24
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  ((1R,2R)-2-(((tert-butyldiphenylsilyl)oxy)methyl)cyclopropyl)methanol 在 重铬酸吡啶 、 草酰氯 、 potassium trisiamylborohydride 、 5A molecular sieve 、 四丁基氟化铵 、 sodium hydride 、 二甲基亚砜 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 67.5h， 生成 (1R)-1-[(1R,2R)-2-(hydroxymethyl)cyclopropyl]ethanol
  参考文献：
  名称：

  对结构简化的底物进行氢化还原环丙基酮的系统研究。通过一分为二的s-顺式构象，可以高度立体选择性地还原反式取代的环丙基酮。

  摘要：

  基于环丙基酮的密度泛函理论（DFT）的从头算计算表明（1）等分的s-顺式和s-反式构象异构体是仅有的两个最小能量构象异构体，而s-顺式构象异构体比s稳定。 -反式和（2）酰基部分中的大体积烷基和环丙烷环上的顺式取代基使平分的s-顺式构象异构体更加稳定。基于这些计算和实验结果，很可能底物的一分为二的s-顺式构象异构体越稳定，氢化物还原的立体选择性就越大。因此，立体化学可以通过氢化物从受阻较少的面上对基底的一分为二的s-顺式构象的攻击来解释。立体化学结果的可预测性基于等分的s-顺式过渡态模型，

  DOI：

  10.1021/jo030019v
• 作为产物：
  描述：

  (1R,2R)-2-(tert-butyldiphenylsilyloxy)methyl-1-formylcyclopropane 在 sodium tetrahydroborate 作用下， 以 甲醇 为溶剂， 生成 ((1R,2R)-2-(((tert-butyldiphenylsilyl)oxy)methyl)cyclopropyl)methanol
  参考文献：
  名称：

  Synthesis of optically active cis- and trans-1,2-disubstituted cyclopropane derivatives by the Simmons-Smith reaction of allyl alcohol derivatives derived from (R)-2,3-O-isopropylideneglyceraldehyde

  摘要：

  The Simmons-Smith reactions of Z- and E-allyl alcohol derivatives 6 derived from (R)-2,3-O-isopropylideneglyceraldehyde (5) were used for the synthesis of optically active cis- and trans-1,2 disubstituted cyclopropane derivatives. Reaction of 6 with diethyl zinc and diiodomethane gave cyclopropane derivatives 7 in 84% to quantitative yields with 35 to approximate to 100% des. Identical facial selectivities toward the double bonds, Ire-asi for Z-6 and 1re-2re for E-6, were observed in the cyclopropanations. The diastereoselectivity was dependent on the protecting group on the terminal allylic oxygen (R of 6, TBDPS > MOM > Bn) and on the stereochemistry of the double bond (Z > E). For TBDPS ethers Z- and E-6c, cis- and trans-7c were obtained as single diastereomers respectively. It was clearly demonstrated that the stereoselectivity of the cyclopropanation is controlled by the directing effect of the allylic oxygen (O-1) of the dioxolane ring which coordinates to the reagent. The terminal allylic oxygen (O-2) lowered the diastereoselectivity This reaction was applied to the synthesis of optically active cyclopropane analogs of gamma-aminobutyric acid (GABA) 18, 22, and ent-22.

  DOI：

  10.1021/jo00080a017

文献信息

• <i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-Tetraalkyl-2,2′-dihydroxy-1,1′-binaphthyl-3,3′-dicarboxamides: Novel Chiral Auxiliaries for Asymmetric Simmons–Smith Cyclopropanation of Allylic Alcohols and for Asymmetric Diethylzinc Addition to Aldehydes
  作者：Hiroshi Kitajima、Katsuji Ito、Yuko Aoki、Tsutomu Katsuki

  DOI：10.1246/bcsj.70.207

  日期：1997.1

  efficient chiral auxiliaries for the asymmetric Simmons–Smith cyclopropanation of allylic alcohols and for asymmetric addition of diethylzinc to aldehydes. For example, Simmons-Smith cyclopropanation of cinnamyl alcohol in the presence of N,N,N′,N′-tetraethyl-2,2′-dihydroxy-1,1′-binaphthyl-3,3′-dicarboxamide (1b) proceeded with high enantioselectivity of 94% ee and addition of diethylzinc to benzaldehyde

  发现新引入的标题化合物是烯丙醇的不对称 Simmons-Smith 环丙烷化和二乙基锌与醛的不对称加成的有效手性助剂。例如，在 N,N,N',N'-tetraethyl-2,2'-dihydroxy-1,1'-binaphthyl-3,3'-dicarboxamide (1b) 存在下肉桂醇的 Simmons-Smith 环丙烷化反应进行在 N,N,N',N'-四异丙基-2,2'-二羟基-1,1'-联萘-3,3'-二甲酰胺存在下，具有 94% ee 的高对映选择性和二乙基锌与苯甲醛的加成（ 1e) 以 99% ee 的对映选择性进行。尽管这些反应的反应机理仍然是核反应，但单体七元 2,2'-二羟基-1,1'-联萘-3,3'-二甲酰胺 (1)-Zn 复合物被认为是一种活性物质，催化上述反应，
• Studies towards the total synthesis of solanoeclepin A: synthesis and potato cyst nematode hatching activity of analogues containing the tetracyclic left-hand substructureElectronic supplementary information (ESI) available: further experimental details. See http://www.rsc.org/suppdata/p1/b2/b202020n/
  作者：Jorg C. J. Benningshof、Maarten IJsselstijn、Sabine R. Wallner、Anne L. Koster、Richard H. Blaauw、Angeline E. van Ginkel、Jean-François Brière、Jan H. van Maarseveen、Floris P. J. T. Rutjes、Henk Hiemstra

  DOI：10.1039/b202020n

  日期：2002.7.11

  In our studies towards the total synthesis of solanoeclepin A, a natural hatching agent of potato cyst nematodes, three analogues containing the tetracyclic left-handed substructure have been synthesised. First, the synthesis of the parent tetracycle 2 in enantiopure form is reported. Key steps are (1) chromium-mediated coupling of aldehyde 5 (see preceding paper in this issue) and vinyl triflate 6 to furnish an α,β-unsaturated lactone, which was transformed into triene 4 in six-steps, (2) ring-closing metathesis of 4 to tetracycle 3 and (3) oxidative functionalisation of the least substituted double bond of 3 to provide the fully functionalised tetracyclic left-handed substructure of solanoeclepin A. The methodology developed was successfully applied in the synthesis of two more elaborate solanoeclepin A analogues 9 and 11. Both compounds, prepared as mixtures of diastereomers, showed promising biological activity in hatching activity tests.

  在我们对马铃薯胞囊线虫天然孵化剂solanoeclepin A的全合成研究中，已经合成了三个含有四环左手子结构的类似物。首先，报道了母四环2的手性纯粹形式的合成。关键步骤是（1）通过铬介导的醛5（见本期前文）和乙烯基三氟磺酸盐6的耦合，得到α，β-不饱和内酯，经过六步转变为三烯4，（2）4的环闭合金属转移反应形成四环3，以及（3）3上最少取代的双键的氧化功能化，得到solanoeclepin A的完全功能化的四环左手子结构。所开发的方法成功地应用于合成两个更复杂的solanoeclepin A类似物9和11。这两个化合物均以非对映异构体混合物形式制备，并在孵化活性测试中显示出有希望的生物活性。
• [EN] MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES<br/>[FR] INHIBITEURS MACROCYCLIQUES DE PEPTIDYLARGININE DÉIMINASES
  申请人：GILEAD SCIENCES INC

  公开号：WO2021222353A1

  公开（公告）日：2021-11-04

  The present disclosure relates to novel compounds for use in therapeutic treatement of a disease associated with peptidylarginine deiminases (PADs), such as peptidylarginine deiminase type 4 (PAD4). The present disclosure also relates to processes and intermediates for the preparation of such compounds, methods of using such compounds and pharmaceutical compositions comprising the compounds described herein.

  本公开涉及用于治疗与肽精氨酸脱亚氨酶（PADs）相关的疾病的新化合物，例如肽精氨酸脱亚氨酶类型4（PAD4）。本公开还涉及用于制备这些化合物的过程和中间体，使用这些化合物的方法以及包含所述化合物的药物组合物。
• Synthesis and Biopharmaceutical Evaluation of Imatinib Analogues Featuring Unusual Structural Motifs
  作者：Kyriacos C. Nicolaou、Dionisios Vourloumis、Sotirios Totokotsopoulos、Athanasios Papakyriakou、Holger Karsunky、Hanan Fernando、Julia Gavrilyuk、Damien Webb、Antonia F. Stepan

  DOI：10.1002/cmdc.201500510

  日期：2016.1

  properties (e.g., ABL1 kinase inhibitory activity, cytotoxicity). The bicyclo[1.1.1]pentane‐ and cubane‐containing analogues were found to possess higher themodynamic solubility, whereas cubane‐ and cyclohexyl‐containing analogues exhibited the highest inhibitory activity against ABL1 kinase and the most potent cytotoxicity values against cancer cell lines K562 and SUP‐B15. Molecular modeling was employed

  设计了一种便捷合成的伊马替尼，一种有效的ABL1激酶抑制剂和治疗各种白血病的处方药，并将其用于构建一系列具有许多非芳香族结构基序的新型伊马替尼类似物母体分子的苯基部分。随后评估这些类似物的生物药学特性（例如，ABL1激酶抑制活性，细胞毒性）。发现含双环[1.1.1]戊烷和古巴的类似物具有更高的热力学溶解度，而含古巴和环己基的类似物对ABL1激酶表现出最高的抑制活性，并且对癌细胞系K562和K562的细胞毒性值最强。 SUP-B15。
• [EN] MACROCYCLIC FLU ENDONUCLEASE INHIBITORS<br/>[FR] INHIBITEURS MACROCYCLIQUES D'ENDONUCLÉASE DE LA GRIPPE
  申请人：JANSSEN BIOPHARMA INC

  公开号：WO2020075080A1

  公开（公告）日：2020-04-16

  The present invention relates to macrocyclic pyridotriazine derivatives of formula (I) and the pharmaceutically acceptable salts, solvates or or polymorph thereof, and the use of such compounds as a medicament, in particular in the prevention and/or treatment of viral infections caused by viruses belonging to the Orthomyxoviridae famiIy. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, and to the compositions or preparations for use as a medicament, more preferably for the prevention or treatment of viral infections caused by viruses belonging to the Orthomyxoviridae family.

  本发明涉及公式（I）的大环吡啶三嗪衍生物及其药学上可接受的盐、溶剂化合物或多型体，以及将这些化合物作为药物的用途，特别是用于预防和/或治疗由属于Orthomyxoviridae家族的病毒引起的病毒感染。本发明还涉及药物组合物或混合制剂，以及用作药物的组合物或制剂，更偏好用于预防或治疗由属于Orthomyxoviridae家族的病毒引起的病毒感染。